Drawing for FITRUS

USPTO serial 79230260

FITRUS

Reviewed by CopyMark Law Group

Reg. 5699867Status 706Registered
Filing date
Status date
Registration date
Mar 19, 2019
Examiner
GLASSER, CARYN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with FITRUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David K. Ho

David K. Ho Harvest IP Law LLP1455 Pennsylvania Avenue NW, Suite 400Washington, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
010BODY COMPOSITION ANALYZERS FOR MEDICAL PURPOSES; BODY COMPOSITION MONITORS; MEDICAL INSTRUMENTS FOR OBESITY TREATMENT, NAMELY, BODY FAT CALIPERS, BODY FAT MONITORS; OBESITY MEASURING INSTRUMENTS FOR MEDICAL PURPOSES, NAMELY, BODY FAT CALIPERS, BODY FAT MONITORS; BIOMETRIC MONITORING APPARATUS FOR MEDICAL PURPOSES, NAMELY, SENSORS FOR MEDICAL USE TO BE WORN BY A HUMAN TO GATHER HUMAN BIOMETRIC DATA; BIOMETRIC MEASURING DEVICES FOR MEDICAL PURPOSES, NAMELY, SENSORS FOR MEDICAL USE TO BE WORN BY A HUMAN TO GATHER HUMAN BIOMETRIC DATA; METABOLIC LOAD MEASURING INSTRUMENTS FOR MEDICAL PURPOSES, NAMELY, MEDICAL IMAGING APPARATUS; HEART RATE MONITORS; BODY FAT MONITORS; BODY FAT ANALYZERS FOR MEDICAL PURPOSES; STATIC ELECTRIC THERAPY APPARATUS; HIGH FREQUENCY ELECTROMAGNETIC THERAPY APPARATUS; MEDICAL APPARATUS AND INSTRUMENTS IN THE FIELDS OF CLINICAL DIAGNOSIS, NAMELY, CLINICAL THERMOMETERS; MEDICAL DIAGNOSTIC APPARATUS, ANALYTICAL APPARATUS FOR MEDICAL PURPOSES AND BLOOD PRESSURE MEASURING APPARATUS; DIAGNOSTIC APPARATUS AND INSTRUMENTS FOR MEDICAL PURPOSES, NAMELY, BLOOD PRESSURE MONITORS, THERMOMETERS; PERCUSSION HAMMERS FOR DIAGNOSTIC PURPOSES; IN VITRO DIAGNOSTIC DEVICES FOR MEDICAL PURPOSES, NAMELY, BLOOD GLUCOSE METERS; MEDICAL BODY COMPOSITION MONITORS; MOBILE MONITORING SCANNERS FOR MEDICAL PURPOSES, NAMELY, MEDICAL BODY COMPOSITION MONITORSACTIVE—
044MEDICAL AND HEALTH CARE SERVICES; MEDICAL AND HEALTH CARE CLINIC SERVICES; TELEMEDICINE SERVICES; PROVISION OF HEALTH INFORMATION; PROVISION OF MEDICAL INFORMATION FROM A WEBSITE; MEDICAL INFORMATION; MEDICAL INFORMATION SERVICES PROVIDED VIA THE INTERNET; PROVIDING INFORMATION IN THE FIELD OF MEDICINE; PROVIDING MEDICAL INFORMATION RELATING TO PHYSICAL EXAMINATIONS; PROVIDING HEALTH CARE INFORMATION BY TELEPHONE; PROVIDING HEALTH CARE INFORMATION BY TELEPHONE AND THE INTERNET; PROVIDING HEALTH CARE INFORMATION VIA A WEBSITE; PROVIDING HEALTH CARE INFORMATION VIA A GLOBAL COMPUTER NETWORK; PROVIDING HEALTH CARE INFORMATION VIA ELECTRONIC MEANS; PHYSICAL EXAMINATION SERVICES; HEALTH COUNSELING; HEALTH CARE; MANAGED HEALTH CARE SERVICES; CONSULTANCY SERVICES RELATING TO HEALTH CARE; ADVISORY SERVICES RELATING TO HEALTH CAREACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 29, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Dec 29, 202571AGREGISTERED-SEC.71 ACCEPTED—
Dec 23, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jul 3, 2025PR71POST REGISTRATION ACTION MAILED - SEC.71—
Jun 30, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 19, 2025ES71TEAS SECTION 71 RECEIVED—
Aug 2, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 11, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 11, 2019FIMPFINAL DISPOSITION PROCESSED—
Jun 19, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 19, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2018NPUBNOTICE OF PUBLICATION—
Nov 29, 2018CNEAEXAMINERS AMENDMENT MAILED—
Nov 28, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 28, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Nov 28, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 26, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 26, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 25, 2018ALIEASSIGNED TO LIE—
Oct 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 19, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2018RFNTREFUSAL PROCESSED BY IB—
Apr 20, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 19, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 19, 2018RFRRREFUSAL PROCESSED BY MPU—
Apr 17, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 16, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2018DOCKASSIGNED TO EXAMINER—
Apr 16, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 12, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance